Whoop Women's Health
A 54-biomarker women's health panel inspired by the WHOOP Women's Health Panel — fertility, cycle and thyroid hormones plus a complete metabolic and nutrient base.
Your adrenal glands make cortisol in a series of steps, and 17-OH-progesterone is one of those intermediate steps. The enzyme 21-hydroxylase converts 17-OH-progesterone into 11-deoxycortisol, from which your adrenal gland then makes cortisol.
When 21-hydroxylase works too little, 17-OH-progesterone piles up and the adrenal gland turns part of it into male sex hormones; that inherited condition is called congenital adrenal hyperplasia (CAH). Only a blood test shows how high your 17-OH-progesterone is.
17-OH-progesterone is expressed in nanomoles per litre (nmol/L), and Star-SHL and Diagnostiek voor U give only an upper limit per sex and age for adults. For men aged 40 to 50 that limit is < 4.05 nmol/L at both, for women of that age < 2.36 nmol/L.
Doctor's Assessment Included
17-OH-progesterone is an intermediate step in the making of cortisol in the adrenal gland, and the standard measurement for establishing congenital adrenal hyperplasia (CAH). The limit differs per laboratory, age, sex and cycle phase.
See the value that applies to you:
Choose male or female — this range differs by sex.
Enter your age — this range changes with age.
This range also depends on context such as cycle phase or sample material; the highlighted rows apply to your group.
Reference ranges may vary between laboratories. When you order a test, a BIG-registered doctor assesses your personal results in context. For treatment decisions, discuss your results with your GP.
Check your own value| Laboratory | Group | Reference value (nmol/L) | Relative scale |
|---|---|---|---|
| Star-shl | · Male · 20–29 years · a limit, not a range | < 3.44 nmol/L |
3.44
|
| Star-shl | · Female · 20–29 years · a limit, not a range | < 2.54 nmol/L |
2.54
|
| Star-shl | · Male · 30–39 years · a limit, not a range | < 3.84 nmol/L |
3.84
|
| Star-shl | · Female · 30–39 years · a limit, not a range | < 2.57 nmol/L |
2.57
|
| Star-shl | · Male · 40–49 years · a limit, not a range | < 4.05 nmol/L |
4.05
|
| Star-shl | · Female · 40–49 years · a limit, not a range | < 2.36 nmol/L |
2.36
|
| Star-shl | · Male · 50 years and older · a limit, not a range | < 3.93 nmol/L |
3.93
|
| Star-shl | · Female · 50 years and older · a limit, not a range | < 2.05 nmol/L |
2.05
|
| Unilabs | · Female · 18–50 years · follicular phase | 0.45–3.00 nmol/l |
0.45 3
|
| Unilabs | · Female · 18–50 years · luteal phase | 1.0–8.5 nmol/l |
1 8.5
|
| Unilabs | · Female · 50 years and older · a limit, not a range | < 1.6 nmol/l |
1.6
|
| Unilabs | · Male · 18 years and older | 1.0–7.5 nmol/l |
1 7.5
|
| Certe | · Female · 20–49 years | 0.23–7.56 nmol/L |
0.23 7.56
|
| Certe | · Female · 49–59 years | 0.32–5.24 nmol/L |
0.32 5.24
|
| Certe | · Female · 59–70 years | 0.31–3.75 nmol/L |
0.31 3.75
|
| Certe | · Female · 70–79 years | 0.36–2.36 nmol/L |
0.36 2.36
|
| Certe | · Male · 20–40 years | 1.83–6.47 nmol/L |
1.83 6.47
|
| Certe | · Male · 40–79 years | 1.30–7.62 nmol/L |
1.3 7.62
|
| Diagnostiek voor U | · Female · 20–29 years · a limit, not a range | < 2.54 nmol/L |
2.54
|
| Diagnostiek voor U | · Female · 30–39 years · a limit, not a range | < 2.57 nmol/L |
2.57
|
| Diagnostiek voor U | · Female · 40–49 years · a limit, not a range | < 2.36 nmol/L |
2.36
|
| Diagnostiek voor U | · Female · 50 years and older · a limit, not a range | < 2.05 nmol/L |
2.05
|
| Diagnostiek voor U | · Female · a limit, not a range · follicular phase | < 2.12 nmol/L |
2.12
|
| Diagnostiek voor U | · Female · a limit, not a range · luteal phase | < 8.78 nmol/L |
8.78
|
| Diagnostiek voor U | · Male · 20–29 years · a limit, not a range | < 3.44 nmol/L |
3.44
|
| Diagnostiek voor U | · Male · 30–39 years · a limit, not a range | < 3.84 nmol/L |
3.84
|
| Diagnostiek voor U | · Male · 40–49 years · a limit, not a range | < 4.05 nmol/L |
4.05
|
| Diagnostiek voor U | · Male · 50 years and older · a limit, not a range | < 3.93 nmol/L |
3.93
|
Source: Star-shl
Source: Unilabs
Source: Certe
Source: Diagnostiek voor U
Each value as the laboratory itself publishes it, retrieved in 2026.
A 17-OH-progesterone test gives the number of nanomoles of 17-hydroxyprogesterone in each litre of your serum, the clear part of the blood after clotting. Star-SHL has the value measured at the Algemeen Medisch Laboratorium (AML) with LC-MS/MS, a technique that first separates substances and then recognises them by their mass, and the Endocrine Society guideline also opts for that technique.
Laboratories do not all use the same limits for 17-OH-progesterone: Unilabs gives 1 to 7.5 nmol/l for men from age 18, whereas Star-SHL names only an upper limit of < 3.44 nmol/L for men aged 20 to 30.
17-OH-progesterone is the blood value doctors use to show congenital adrenal hyperplasia (CAH): according to the Endocrine Society guideline, a measurement of 17-OH-progesterone is still the standard for that diagnosis, most often together with a stimulation test. According to the guideline, CAH arises in about 95% of cases from a fault in the gene CYP21A2, which holds the blueprint for 21-hydroxylase.
In people past infancy who have symptoms, the Endocrine Society guideline advises a 17-OH-progesterone test on blood drawn before 8 am. In the mild form of CAH, a measurement at a random time can give a normal outcome according to the guideline, which is why an early-morning measurement is preferred.
If the doctor is in doubt about the result, the guideline says a stimulation test with cosyntropin follows, a form of ACTH that drives the adrenal gland to maximum production.
A low 17-OH-progesterone sits within the reference values at Star-SHL and Diagnostiek voor U, because both labs name only an upper limit for adults, such as < 2.57 nmol/L for women aged 30 to 40. The Endocrine Society guideline links no symptoms or condition to a low value.
The mild form of CAH, one cause of a high 17-OH-progesterone, gives varying signs of excess male hormones and sometimes no symptoms at all, according to the Endocrine Society guideline. According to the guideline, the mild form generally does not cause an adrenal crisis.
Congenital adrenal hyperplasia from 21-hydroxylase deficiency
According to the Endocrine Society guideline, CAH is caused in about 95% of cases by a fault in the gene for 21-hydroxylase; that enzyme converts 17-OH-progesterone, and with a shortage 17-OH-progesterone builds up.
Mild (nonclassic) CAH
In the mild form, a 17-OH-progesterone measured at a random time can be normal; that is why the guideline advises blood drawn before 8 am.
Other adrenal enzyme shortages
According to the guideline, 17-OH-progesterone can also be raised with a shortage of 11-beta-hydroxylase and, more rarely, of 3-beta-hydroxysteroid dehydrogenase or P450 oxidoreductase.
Pregnancy
According to the guideline, 17-OH-progesterone in the mother is raised in a normal pregnancy.
Second half of the menstrual cycle
In the luteal phase the value is higher: Unilabs then uses 1.0 to 8.5 nmol/l, against 0.45 to 3 nmol/l in the follicular phase, for women aged 18 to 50.
With a raised 17-OH-progesterone, the next step is up to the doctor, who according to the Endocrine Society guideline arranges a stimulation test and a complete profile of adrenal hormones when the value is borderline. When the mild form of CAH is diagnosed in an adult, the guideline recommends genetic counselling by someone familiar with the condition.
According to the Endocrine Society guideline, 17-OH-progesterone is measured before 8 am because a value at a random moment can be normal in the mild form of CAH. The guideline also advises a measurement with LC-MS/MS.
No, a 17-OH-progesterone above the limit does not have to come from CAH with a 21-hydroxylase shortage. According to the Endocrine Society guideline, the value can also be raised with a shortage of 11-beta-hydroxylase and, more rarely, with two other enzyme shortages, and a normal pregnancy also raises the mother's 17-OH-progesterone, according to the guideline.
Carriership exists in CAH from a shortage of 21-hydroxylase, the inherited condition in which 17-OH-progesterone builds up: according to the Endocrine Society guideline, each later brother or sister of someone with CAH has a 50% chance of being a carrier without symptoms, and a 25% chance of having the condition itself. A 17-OH-progesterone test does not reliably show carriership, because the slightly higher value of carriers after stimulation overlaps with that of non-carriers; the guideline calls genetic testing the better method.
These panels measure values from the same category as this marker.
A 54-biomarker women's health panel inspired by the WHOOP Women's Health Panel — fertility, cycle and thyroid hormones plus a complete metabolic and nutrient base.
A 49-biomarker men's health panel inspired by the WHOOP Men's Health Panel — testosterone, PSA and prostate health plus a complete metabolic and hormone base.
A 51-biomarker performance panel inspired by the WHOOP Performance Health Panel — recovery, blood production, thyroid, hormones, iron and nutrient status for people who train.
A 45-biomarker comprehensive health panel inspired by WHOOP Advanced Labs — a deep look at metabolism, cardiovascular risk, hormones, liver, kidney and inflammation.
Doctor's Assessment Included
Every result includes a professional assessment from a BIG-registered doctor. For treatment decisions, discuss your results with your GP.
17-OH Progesterone
€81,-
We use cookies to analyze site usage and measure ad effectiveness. Privacy Policy